Yee Ying Leung
Algemeen Directeur bij Antiviral Technologies, Inc.
Profiel
Yee Ying Leung is the founder of Walcom Group Ltd.
Currently, Ms. Leung is the Chief Executive Officer & Director at Antiviral Technologies, Inc. Ms. Leung completed an undergraduate degree from the University of Toronto in 1985.
Actieve functies van Yee Ying Leung
| Bedrijven | Functie | Begin |
|---|---|---|
Antiviral Technologies, Inc.
 Antiviral Technologies, Inc. Financial ConglomeratesFinance Antiviral Technologies, Inc. operates as a development stage biotechnology company utilizing cysteamine compositions in the development of antiviral drugs for human application. It operates business through subsidiary Obio Pharmaceutical (HK) Ltd. The company has offices in Beijing and Hong Kong. Antiviral Technologies was founded on September 13, 2007 and is headquartered in Hong Kong. | Algemeen Directeur | 28-03-2014 |
Eerdere bekende functies van Yee Ying Leung
| Bedrijven | Functie | Einde |
|---|---|---|
| WALCOM GROUP LIMITED | Oprichter | - |
Opleiding van Yee Ying Leung
| University of Toronto | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Antiviral Technologies, Inc.
Antiviral Technologies, Inc. Financial ConglomeratesFinance Antiviral Technologies, Inc. operates as a development stage biotechnology company utilizing cysteamine compositions in the development of antiviral drugs for human application. It operates business through subsidiary Obio Pharmaceutical (HK) Ltd. The company has offices in Beijing and Hong Kong. Antiviral Technologies was founded on September 13, 2007 and is headquartered in Hong Kong. | Finance |
Walcom Group Ltd.
 Walcom Group Ltd. Pharmaceuticals: GenericHealth Technology Walcom Group Ltd. is a holding company, which engages in the research, development, commercialization, production and marketing of animal feed additive products. Its products include Porcinin Plus, Porcimax, Eggronin Plus, and Aquanin Plus. It operates through the following geographical segments: Hong Kong, China, Philippines, Thailand, Taiwan, Other Asia-Pacific Countries, Europe and the United Kingdom, America and Canada, and Others. The company was founded in 2004 and is headquartered in Shanghai, China. | Health Technology |
